FOXO TECHNOLOGIES INC.’S CRITICAL ACCESS HOSPITAL ANNOUNCES NEW WOUND CARE SERVICES OFFERING

Rhea-AI Summary

FOXO Technologies Inc. (NYSE American: FOXO) has announced that its Big South Fork Medical Center in Oneida, Tennessee, has begun offering wound care services for both inpatient and outpatient treatment. The expansion addresses growing demand in the service area, particularly focusing on diabetic patients who face challenges with wound healing due to excessive inflammation and reduced angiogenesis. CEO Seamus Lagan indicated that this service expansion is expected to increase net revenues, and the company is exploring additional service offerings at the Oneida campus and other regional locations.

Positive

• Expansion of medical services to include wound care treatment, addressing growing market demand
• Focus on serving diabetic patients, a significant market segment with specific wound care needs
• Expected increase in net revenues from new service offering
• Potential for further service expansion at Oneida campus and other regional locations

Negative

• None.

News Market Reaction

-3.45%

1 alert

-3.45% News Effect

On the day this news was published, FOXO declined 3.45%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

WEST PALM BEACH, FLORIDA, June 17, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its critical access hospital, Big South Fork Medical Center located in Oneida, Tennessee, has commenced offering wound care services to patients both on an inpatient and outpatient basis. The hospital has experienced a growing demand for wound care services in its market service area, particularly for diabetic patients who have wounds often characterized by excessive inflammation and reduced angiogenesis and have a higher risk for postoperative wound healing complications.

“We are pleased that our critical access hospital in rural, East Tennessee is expanding its services that will, in turn, increase net revenues and we are working closely with hospital leadership to further expand our market reach which may include other, needed service offerings at our Oneida campus or other locations in the region,” stated Seamus Lagan, Chief Executive Officer of parent company, FOXO Technologies Inc.

About FOXO Technologies Inc. (“FOXO”)

FOXO owns and operates three subsidiaries.

Rennova Community Health, Inc., owns and operates Scott County Community Hospital, Inc. (d/b/a Big South Fork Medical Center), a critical access designated (CAH) hospital in East Tennessee.

Myrtle Recovery Centers, Inc., a 30-bed behavioral health facility in East Tennessee. Myrtle provides inpatient services for detox and residential treatment and outpatient services for MAT and OBOT Programs.

FOXO Labs, Inc. is a biotechnology company dedicated to improving human health and life span through the development of cutting-edge technology and product solutions for various industries.

For more information about FOXO, visit www.foxotechnologies.com.

Forward-Looking Statements

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the FOXO’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. These factors include, but are not limited to the risk of changes in the competitive and highly regulated industries in which FOXO operates; variations in operating performance across competitors or changes in laws and regulations affecting FOXO’s business; the ability to implement FOXO’s business plans, forecasts, and other expectations; the ability to obtain financing; the risk that FOXO has a history of losses and may not achieve or maintain profitability in the future; potential inability of FOXO to establish or maintain relationships required to advance its goals or to achieve its commercialization and development plans; the enforceability of FOXO’s intellectual property, including its patents and the potential infringement on the intellectual property rights of others; and the risk of downturns and a changing regulatory landscape in the highly competitive biotechnology industry or in the markets or industries in which FOXO operates. The foregoing list of factors is not exhaustive. Readers should carefully consider the foregoing factors and the other risks and uncertainties discussed in FOXO’s most recent reports on Forms 10-K and 10-Q, particularly the “Risk Factors” sections of those reports, and in other documents FOXO has filed, or will file, with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and FOXO assumes no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact:

Sebastien Sainsbury
ssainsbury@foxotechnologies.com
(561) 485-0151

FAQ

What new services is FOXO Technologies (FOXO) adding to its Big South Fork Medical Center?

FOXO Technologies is adding wound care services for both inpatient and outpatient treatment at its Big South Fork Medical Center in Oneida, Tennessee.

How will the new wound care services affect FOXO Technologies' revenue?

According to CEO Seamus Lagan, the new wound care services are expected to increase net revenues for the company.

What specific patient group is FOXO Technologies targeting with its new wound care services?

The services particularly target diabetic patients who face challenges with wound healing due to excessive inflammation and reduced angiogenesis.

What are FOXO Technologies' future expansion plans for Big South Fork Medical Center?

The company is working with hospital leadership to expand market reach, potentially including additional service offerings at the Oneida campus and other locations in the region.